Aegis Sciences Corporation, the Nashville forensic toxicology and drug testing lab, has been a party to four notable lawsuits: a defamation suit against political candidate Lou Ann Zelenik over 2010 campaign ads, a kickback-and-unfair-competition fight with rival Millennium Laboratories, a Lanham Act false advertising case brought by competitor Ameritox, and a negligence claim from an Illinois pain patient dismissed after a positive drug test. Aegis lost the defamation case on appeal, saw its Millennium case consolidated with Millennium’s earlier-filed action in Florida, was denied attorney’s fees in the Ameritox matter after that suit was dismissed, and prevailed when the Illinois court affirmed dismissal of the patient’s negligence claims.
The Zelenik Defamation Suit
The most public case grew out of the 2010 Republican primary for Tennessee’s 6th Congressional District, which Diane Black — wife of Aegis founder Dr. David L. Black — won by 283 votes over Lou Ann Zelenik in a six-way race.1WGNS Radio. Zelenik Wins Court Lawsuit, Files to Run in 6th District Zelenik’s radio and television ads accused Diane Black of directing $1 million in state funds to Aegis, showing her handing an oversized check to her husband while a narrator said, “Diane Black, big spending that hurt every Tennessee family, except hers.”2Courthouse News Service. Tenn. GOP Candidate Sued Over Campaign Ads
Aegis sued in Davidson County Chancery Court after a July 26, 2010 cease-and-desist letter went unheeded. The complaint alleged that the ads falsely accused the company of “self-dealing, wrongdoing, and illegal, unethical, immoral and corrupt conduct,” and brought claims for defamation, civil conspiracy, and violation of the Tennessee Consumer Protection Act. Aegis said its state contracts were competitively bid, supervised by the governor’s office, and represented only a small share of its revenue.2Courthouse News Service. Tenn. GOP Candidate Sued Over Campaign Ads
On March 21, 2012, Davidson County Circuit Court Judge Joe Binkley granted summary judgment to Zelenik on every claim, ruling the advertisement was “true” and that truth is an absolute defense to defamation.1WGNS Radio. Zelenik Wins Court Lawsuit, Files to Run in 6th District Aegis appealed the defamation and civil conspiracy rulings, but not the consumer protection claim. On January 16, 2013, the Tennessee Court of Appeals affirmed in a majority opinion by Judge David R. Farmer, holding that the ad could not reasonably be construed as defaming Aegis.3Tennessee Courts. Aegis Sciences Corporation v. Lou Ann Zelenik, et al. A dissenting judge would have sent factual disputes about “substantial truth” to a jury.4Midpage. Aegis Sciences Corporation v. Lou Ann Zelenik The case went no further. Zelenik later filed her own suit against Diane Black; Black was deposed in that matter in September 2017.5Tennessee Bar Association. Zelenik Lawsuit Against Black
The Millennium Laboratories Kickback Fight
Aegis and Millennium Laboratories, one of the country’s largest urine drug testing labs, each accused the other of using illegal kickbacks to lure physician referrals and defraud government healthcare programs.
Millennium sued first, filing on January 19, 2011 in Miami-Dade County Circuit Court, with the case then removed to the U.S. District Court for the Southern District of Florida. Millennium alleged that Aegis provided kickbacks through “space lease” arrangements placing Aegis staff in physician offices, used requisition forms designed to generate unnecessary testing, and made misleading claims about lab accreditations. It also brought Lanham Act false advertising claims and deceptive trade practices claims under Florida, Georgia, and Tennessee law.6vLex. Aegis Sciences Corp. v. Millennium Laboratories
Aegis fired back on March 29, 2011 in the U.S. District Court for the Middle District of Tennessee. Its complaint alleged that Millennium offered kickbacks in the form of free staff and services, used prohibited fee arrangements to lease equipment to physicians, and engaged in illegal practices to maximize reimbursement and drive referrals.7CaseMine. Aegis Sciences Corp. v. Millennium Laboratories Inc.
On August 4, 2011, Judge Kevin Hunter Sharp granted Millennium’s motion to transfer the Tennessee case to the Southern District of Florida, finding the two actions involved substantially overlapping allegations. All other pending motions were denied as moot.7CaseMine. Aegis Sciences Corp. v. Millennium Laboratories Inc. The final outcome of the consolidated Florida litigation is not publicly reported.
The kickback allegations gained context in October 2015, when Millennium Health agreed to pay $256 million to settle federal claims that it had billed Medicare, Medicaid, and other government programs for medically unnecessary drug and genetic testing and had provided illegal inducements to referring physicians.8U.S. Department of Justice. Millennium Health Agrees to Pay $256 Million to Resolve Allegations of Unnecessary Drug and Genetic Testing The government alleged Millennium used standing-order “custom profiles” that bypassed individualized patient assessments and gave free drug test cups to physicians on the condition that they refer specimens to Millennium.9U.S. Department of Justice. Millennium Laboratories to Pay $256 Million to Resolve False Billing and Kickback Claims The settlement resolved whistleblower suits and required Millennium to enter a five-year Corporate Integrity Agreement with the HHS Office of Inspector General. Those federal claims were separate from the private suit between the two labs, but they involved the same category of conduct Aegis had described in its own complaint years earlier.
The Ameritox Lanham Act Case
In 2008, competitor Ameritox, Ltd. sued Aegis in the U.S. District Court for the Northern District of Texas, asserting a Lanham Act false advertising claim. Ameritox had first tried to add the same claim to an existing lawsuit in the Southern District of Florida, but that request was denied. The Texas court dismissed the new action under the rule against claim-splitting, holding that Ameritox could not pursue in a second forum a claim it had already been refused permission to add in the first.10GovInfo. Ameritox, Ltd. v. Aegis Sciences Corp., 3:08-CV-1168-D
Aegis then moved for attorney’s fees under the Lanham Act, arguing the case was “exceptional” because Ameritox filed a claim it knew or should have known was barred. In a May 2009 opinion, Chief Judge Sidney A. Fitzwater denied the motion, ruling that Aegis had not shown by clear and convincing evidence that Ameritox’s decision to file was “so implausible as to necessitate an inference of bad faith.”10GovInfo. Ameritox, Ltd. v. Aegis Sciences Corp., 3:08-CV-1168-D
The Gaylord Negligence Suit in Illinois
A patient case tested how far a testing lab’s duty extends to the people whose specimens it analyzes. Curtis Gaylord sued Presence Pain Care and Aegis in Illinois state court after Aegis reported in 2018 that his oral fluid sample was positive for cocaine and Presence dismissed him from its pain medication program. Gaylord said the result was a false positive and argued the defendants were negligent for not letting him contest the finding.11Illinois Courts. Gaylord v. Presence Pain Care, 2023 IL App (3d) 210572-U
On August 15, 2023, the Illinois Appellate Court for the Third District affirmed dismissal of the complaint. The court recognized existing precedent that a drug testing lab owes a duty of care to those whose specimens it tests, since a negligent error could foreseeably cause harm. But Gaylord never alleged Aegis had performed the test negligently or reported the results inaccurately, and Aegis had retested the sample at his request and confirmed the original result. The court held there is no legally recognized duty for a lab to give a patient an opportunity to “prove a false-positive.” It also rejected Gaylord’s breach of contract and constitutional claims, noting his treatment agreement expressly allowed immediate termination on a positive test for illegal drugs and that both defendants were private entities not bound by the Fourth, Fifth, or Fourteenth Amendments.11Illinois Courts. Gaylord v. Presence Pain Care, 2023 IL App (3d) 210572-U
Who Aegis Is
Aegis was founded in 1990 by Dr. David L. Black, a forensic toxicologist with a Ph.D. from the University of Maryland, and is headquartered in Nashville.12Vanderbilt University. David L. Black Bio Boston-based Abry Partners acquired the company in a standalone buyout completed in early 2014.13Buyouts Insider. Deals Closed Q1 2014 By 2016 the lab ran about 200 million tests a year, employed roughly 900 people, and was valued at around $750 million.14The Tennessean. Aegis CEO David Black Exits Company David Black left as CEO in late 2016, and Dr. Frank Basile, previously of Miraca Life Sciences, was named CEO in April 2017 and still leads the company.15Aegis Sciences Corporation. Dr. Frank Basile Joins Aegis Sciences Corporation as Chief Executive Officer As of mid-2026, no new lawsuits, settlements, or regulatory actions involving Aegis have been publicly reported.